Transplant Outcomes in Patients with Idiopathic Membranous Nephropathy

Background. The natural history of idiopathic membranous nephropathy and recurrent disease in transplants is variable. We performed a retrospective cohort study of renal transplant recipients with a primary diagnosis of idiopathic membranous nephropathy. We aimed to establish patterns of disease rec...

Full description

Saved in:
Bibliographic Details
Main Authors: Claire Kennedy, Carol Traynor, Patrick O'Kelly, Anthony Dorman, Peter J. Conlon
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:International Journal of Nephrology
Online Access:http://dx.doi.org/10.1155/2013/818537
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832546101748563968
author Claire Kennedy
Carol Traynor
Patrick O'Kelly
Anthony Dorman
Peter J. Conlon
author_facet Claire Kennedy
Carol Traynor
Patrick O'Kelly
Anthony Dorman
Peter J. Conlon
author_sort Claire Kennedy
collection DOAJ
description Background. The natural history of idiopathic membranous nephropathy and recurrent disease in transplants is variable. We performed a retrospective cohort study of renal transplant recipients with a primary diagnosis of idiopathic membranous nephropathy. We aimed to establish patterns of disease recurrence and to identify factors associated with disease recurrence. Methods. We accessed the Irish renal transplant database to identify patients with biopsy-proven idiopathic membranous nephropathy in receipt of a renal transplant between 1982 and 2010. A detailed medical chart review was performed in all cases, and a senior renal histopathologist reviewed all histology specimens. Results. The outcomes of 32 patients, in receipt of 36 grafts, are reported. There was a male preponderance (). Significant graft dysfunction, directly attributable to recurrent disease, was evident in 31% of cases at 10 years. There was no significant association between time on dialysis, HLA mismatch, occurrence of rejection, and the development of recurrent membranous disease. One patient was retransplanted twice; all three grafts were lost to aggressive recurrent membranous disease. Conclusions. It remains difficult to identify those that will develop recurrent membranous nephropathy. Almost one third of patients in this cohort developed clinically significant recurrent disease at 10 years.
format Article
id doaj-art-fbe4219b35a8499e832cd4b0277f34ad
institution Kabale University
issn 2090-214X
2090-2158
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series International Journal of Nephrology
spelling doaj-art-fbe4219b35a8499e832cd4b0277f34ad2025-02-03T07:23:52ZengWileyInternational Journal of Nephrology2090-214X2090-21582013-01-01201310.1155/2013/818537818537Transplant Outcomes in Patients with Idiopathic Membranous NephropathyClaire Kennedy0Carol Traynor1Patrick O'Kelly2Anthony Dorman3Peter J. Conlon4Department of Nephrology, Beaumont Hospital, Dublin 9, IrelandDepartment of Nephrology, Beaumont Hospital, Dublin 9, IrelandDepartment of Nephrology, Beaumont Hospital, Dublin 9, IrelandDepartment of Histopathology, Beaumont Hospital, Dublin 9, IrelandDepartment of Nephrology, Beaumont Hospital, Dublin 9, IrelandBackground. The natural history of idiopathic membranous nephropathy and recurrent disease in transplants is variable. We performed a retrospective cohort study of renal transplant recipients with a primary diagnosis of idiopathic membranous nephropathy. We aimed to establish patterns of disease recurrence and to identify factors associated with disease recurrence. Methods. We accessed the Irish renal transplant database to identify patients with biopsy-proven idiopathic membranous nephropathy in receipt of a renal transplant between 1982 and 2010. A detailed medical chart review was performed in all cases, and a senior renal histopathologist reviewed all histology specimens. Results. The outcomes of 32 patients, in receipt of 36 grafts, are reported. There was a male preponderance (). Significant graft dysfunction, directly attributable to recurrent disease, was evident in 31% of cases at 10 years. There was no significant association between time on dialysis, HLA mismatch, occurrence of rejection, and the development of recurrent membranous disease. One patient was retransplanted twice; all three grafts were lost to aggressive recurrent membranous disease. Conclusions. It remains difficult to identify those that will develop recurrent membranous nephropathy. Almost one third of patients in this cohort developed clinically significant recurrent disease at 10 years.http://dx.doi.org/10.1155/2013/818537
spellingShingle Claire Kennedy
Carol Traynor
Patrick O'Kelly
Anthony Dorman
Peter J. Conlon
Transplant Outcomes in Patients with Idiopathic Membranous Nephropathy
International Journal of Nephrology
title Transplant Outcomes in Patients with Idiopathic Membranous Nephropathy
title_full Transplant Outcomes in Patients with Idiopathic Membranous Nephropathy
title_fullStr Transplant Outcomes in Patients with Idiopathic Membranous Nephropathy
title_full_unstemmed Transplant Outcomes in Patients with Idiopathic Membranous Nephropathy
title_short Transplant Outcomes in Patients with Idiopathic Membranous Nephropathy
title_sort transplant outcomes in patients with idiopathic membranous nephropathy
url http://dx.doi.org/10.1155/2013/818537
work_keys_str_mv AT clairekennedy transplantoutcomesinpatientswithidiopathicmembranousnephropathy
AT caroltraynor transplantoutcomesinpatientswithidiopathicmembranousnephropathy
AT patrickokelly transplantoutcomesinpatientswithidiopathicmembranousnephropathy
AT anthonydorman transplantoutcomesinpatientswithidiopathicmembranousnephropathy
AT peterjconlon transplantoutcomesinpatientswithidiopathicmembranousnephropathy